Entrada Therapeutics, Inc. (TRDA)
6.615
-0.08
(-1.27%)
USD |
NASDAQ |
May 27, 14:59
Entrada Therapeutics Profit Margin (Quarterly) : -4.54K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 34.24% |
| Tyra Biosciences, Inc. | -- |
| Biogen, Inc. | 13.29% |
| Catalyst Pharmaceuticals, Inc. | 42.66% |
| XOMA Royalty Corp. | 29.01% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.45% |
| Return on Assets | -40.30% |
| Return on Invested Capital | -41.96% |
| Gross Profit Margin (Quarterly) | 8.00% |
| Operating Margin (Quarterly) | -4.83K% |
| Return on Net Operating Assets | -227.9% |